The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non–Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

The optimal immune checkpoint inhibitors combined with chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis

Clinical & Translational Oncology ◽

10.1007/s12094-020-02502-8 ◽

2020 ◽

Author(s):

Y. Yang ◽

H. Luo ◽

X. L. Zheng ◽

H. Ge

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Immune checkpoint inhibitors for treatment of small-cell lung cancer: a systematic review and meta-analysis

Annals of Translational Medicine ◽

10.21037/atm-21-1423 ◽

2021 ◽

Vol 9 (8) ◽

pp. 705-705

Author(s):

Zhicheng Niu ◽

Shenghu Guo ◽

Jing Cao ◽

Yuehua Zhang ◽

Xiaojin Guo ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis

Translational Lung Cancer Research ◽

10.21037/tlcr-20-941 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Giorgia Guaitoli ◽

Marcello Tiseo ◽

Massimo Di Maio ◽

Luc Friboulet ◽

Francesco Facchinetti

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Combination of radiotherapy and Immune checkpoint inhibitors for advanced Non-small cell lung cancer: A systematic review and meta-analysis

10.37766/inplasy2020.6.0011 ◽

2020 ◽

Author(s):

Zexi Xu ◽

Huibo Zhang ◽

Yiming Weng ◽

Yao Jin ◽

Min Peng

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Neoadjuvant immune checkpoint inhibitors in resectable non-small-cell lung cancer: a systematic review

ESMO Open ◽

10.1016/j.esmoop.2021.100244 ◽

2021 ◽

Vol 6 (5) ◽

pp. 100244 ◽

Cited By ~ 1

Author(s):

E.B. Ulas ◽

C. Dickhoff ◽

F.L. Schneiders ◽

S. Senan ◽

I. Bahce

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Impact of treatment timing and sequence of immune checkpoint inhibitors and anti-angiogenic agents for advanced non-small cell lung cancer: A systematic review and meta-analysis

Lung Cancer ◽

10.1016/j.lungcan.2021.11.008 ◽

2021 ◽

Author(s):

Kinnosuke Matsumoto ◽

Takayuki Shiroyama ◽

Tomoki Kuge ◽

Kotaro Miyake ◽

Yuji Yamamoto ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Treatment Timing

Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non–small-cell Lung Cancer: A Systematic Review and Meta-analysis

Clinical Lung Cancer ◽

10.1016/j.cllc.2019.11.004 ◽

2020 ◽

Vol 21 (2) ◽

pp. 106-113.e5 ◽

Cited By ~ 2

Author(s):

Jacques Raphael ◽

Anupam Batra ◽

Gabriel Boldt ◽

Prakesh S. Shah ◽

Phillip Blanchette ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Survival Benefit ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

P2.07-055 Indirect Comparison between Immune-Checkpoint Inhibitors for 2nd Line Non-Small Cell Lung Cancer – a Network Meta-Analysis

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.1311 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2150 ◽

Cited By ~ 1

Author(s):

P. Tan ◽

P. Aguiar ◽

B. Haaland ◽

G. Lopes

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Indirect Comparison ◽

Small Cell ◽

Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review

Oncotarget ◽

10.18632/oncotarget.17213 ◽

2017 ◽

Vol 8 (31) ◽

pp. 51779-51785 ◽

Cited By ~ 7

Author(s):

Bum Jun Kim ◽

Jung Han Kim ◽

Hyeong Su Kim

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Survival Benefit ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Comparing strategy of immune checkpoint inhibitors plus chemotherapy with chemotherapy alone for small cell lung cancer: a meta-analysis based on six RCTs incorporating 2800 participants

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-021-03798-x ◽

2021 ◽

Author(s):

Yaqi Zhong ◽

Qing Wu ◽

Sumei Wu ◽

Xianhe Xie

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽